Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Automated Imaging Differentiation of Parkinsonism
NCT05913687 · View on ClinicalTrials.gov ↗
Study Summary
The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST AIDP
Study Locations (20)
California
- University of California San Diego — La Jolla
- University of California San Francisco — San Francisco
Florida
- University of Florida — Gainesville
- University of South Florida — Tampa
Illinois
- Northwestern University — Chicago
- University of Chicago — Chicago
Massachusetts
- Beth Israel Deaconess Medical Center — Boston
- Massachusetts General Hospital — Charlestown
North Carolina
- Duke University Medical Center — Durham
- Wake Forest University — Winston-Salem
Alabama
- University of Alabama at Birmingham — Birmingham
Georgia
- Augusta University — Augusta
Kentucky
- University of Kentucky — Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2021-07-22 |
| Est. Completion | 2026-03-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05913687
The ClinicalTrials.gov registry entry for NCT05913687 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 315 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,066 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention — of which AIDP is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05913687 reports 20 study locations spanning 15 distinct geographic areas — top geographies include California, Florida, Illinois. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05913687 about?
NCT05913687 is a clinical study titled "Automated Imaging Differentiation of Parkinsonism". The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and ...
What is the current status of trial NCT05913687?
This trial is currently active not recruiting. The enrollment target is 315 participants. The study started on 2021-07-22. Estimated completion is 2026-03-31.
What conditions does trial NCT05913687 study?
This clinical trial studies the following conditions: Parkinson Disease, Progressive Supranuclear Palsy, Multiple System Atrophy, Parkinson Variant. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05913687?
The interventions under investigation include: AIDP (DIAGNOSTIC_TEST). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05913687?
This trial is sponsored by University of Florida, which has 1,066 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05913687 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.